Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain

Epidemiology and Infection

Volumn 132, Issue 3, 2004, Pages 425-432

  Santin, M ^a   Alcaide, F ^a   Benitez, M A ^a   Salazar, A ^a   Ardanuy, C ^a   Podzamczer, D ^a   Rufi, G ^a   Dorca, J ^a   Martin, R ^a   Gudiol, F ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL VARIATION (SPECIES); GEOGRAPHY; HUMAN; INCIDENCE; MALE; MOLECULAR TYPING; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; NONHUMAN; POPULATION RESEARCH; RETROSPECTIVE STUDY; SPAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; EPIDEMIOLOGIC STUDIES; FEMALE; GENOTYPE; GEOGRAPHY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; RETROSPECTIVE STUDIES; SPAIN;

EID: 2642544839     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S095026880300150X     Document Type: Article

References (32)

1. Bittner MJ, Horowitz EA, Safranek TJ, Preheim LC. Emergence of Mycobacterium kansasii as the leading mycobacterial pathogen isolated over a 20-year period at a midwestern Veterans Affairs hospital. Clin Infect Dis 1996; 22: 1109-1110.
2. Bloch KC, Zwerling L, Pletcher MJ, et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998; 129: 698-704.
3. Good RC, Snider Jr DE. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982; 146: 829-833.
4. Chobot S, Malis J, Sebakova H, et al. Endemic incidence of infections caused by Mycobacterium kansasii in the Karvina district in 1968-1995. Cent Eur J Public Health 1997; 5: 164-173.
5. Kaustova J, Chmelik M, Ettlova D, Hudec V, Nazarova H, Richtrova S. Disease due to Mycobacterium kansasii in the Czech Republic: 1984-1989. Tuberc Lung Dis 1995; 76: 205-209.
6. Witzig RS, Fazal BA, Mera RM, et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1995; 21: 77-85.
7. Valainis GT, Cardona LM, Greer DL. The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients. J Acquir Immune Defic Syndr 1991; 4: 516-520.
8. Sherer R, Sable R, Sonnenberg M, et al. Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 710-712.
9. Lebrun L, Espinasse F, Poveda JD, Vincent-Levy-Frebault V. Evaluation of nonradioactive DNA probes for identification of mycobacteria. J Clin Microbiol 1992; 30: 2476-2478.
10. Ross BC, Jackson K, Yang M, Sievers A, Dwyer B. Identification of a genetically distinct subspecies of Mycobacterium kansasii. J Clin Microbiol 1992; 30: 2930-2933.
11. Picardeau M, Prod'Hom G, Raskine L, LePennec MP, Vincent V. Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol 1997; 35: 25-32.
12. Alcaide F, Richter I, Bernasconi C, et al. Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol 1997; 35: 1959-1964.
13. Richter E, Niemann S, Rüsh-Gerdes S, Hoffner S. Identification of Mycobacterium kansasii by using a DNA probe (AccuProbe) and molecular techniques. J Clin Microbiol 1999; 37: 964-970.
14. Taillard C, Greub G, Weber R, et al. Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss national survey. J Clin Microbiol 2003; 41: 1240-1244.
15. Institut d'Estadística de Catalunya. Estadística de població 1996. Generalitat de Catalunya. Barcelona, 1997: Vol. 1, pp. 3-98.
16. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41: 1-19.
17. American Thoracic Society. Medical section of the American Lung Association. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1-S25.
18. Gullans Sr CR. Digestion-decontamination procedures. In: Isenberg HD, ed. Clinical microbiology procedures handbook. Washington, DC: ASM Press, 1992: 3.4.1-3.4.14.
19. Nolte FS, Metchock B. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th ed. Washington, DC: ASM Press, 1995: 400-437.
20. Telenti A, Marchesi M, Balz M, Bally F, Böttger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993; 31: 175-178.
21. Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M. intracellulare-avium in Texas. Chest 1979; 75: 120-125.
22. Santin M, Alcaide F. Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy. Int J Tuberc Lung Dis 2003; 7: 673-677.
23. Tortoli E, Simonetti MT, Lacchini C, Penati V, Urbano P. Tentative evidence of AIDS-associated biotype of Mycobacterium kansasii. J Clin Microbiol 1994; 32: 1779-1782.
24. Evans SA, Colville A, Evans AJ, Crisp AJ, Johnston ID. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 1996; 51: 1248-1252.
25. Evans AJ, Crisp AJ, Hubbard RB, Colville A, Evans SA, Johnston ID. Pulmonary Mycobacterium kansasii infection: comparison of the radiological appearances with pulmonary tuberculosis. Thorax 1996; 51: 1243-1247.
26. Lillo M, Orengo S, Cernoch P, Harris RL. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 1990; 12: 760-767.
27. Echevarría MP, Martín G, Pérez J, Urkijo JC. Pulmonary disease by Mycobacterium kansasii. Presentation of 27 cases. Enferm Infecc Microbiol Clin 1994; 12: 280-284.
28. Bamberger DM, Driks MR, Gupta MR, et al. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clin Infect Dis 1994; 18: 395-400.
29. Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114: 861-868.
30. Campo RE, Campo CE. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997; 24: 1233-1238.
31. Pintado V, Gómez-Mampaso E, Martín-Dávila P, et al. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1999; 18: 582-586.
32. Capdevila O, Zurita A, Domingo E, et al. Multiple cranial osteolytic lesions due to Mycobacterium kansasii in a patient with AIDS. Scand J Infect Dis 1998; 30: 305-306.